Calamos Advisors’s Prenetics Global Ltd Warrant PRENW Stock Holding History

Calamos Advisors’s Portfolio PRENW Stock Details PRENW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51K	Hold	200,000	–	–	﹤0.01%	973
2026 Q1	$3.5K	Hold	200,000	–	–	﹤0.01%	1187
2025 Q4	$5.62K	Hold	200,000	–	–	﹤0.01%	904
2025 Q3	$5.39K	Hold	200,000	–	–	﹤0.01%	899
2025 Q2	$7.82K	Hold	200,000	–	–	﹤0.01%	889
2025 Q1	$1.87K	Hold	200,000	–	–	﹤0.01%	894
2024 Q4	$1.56K	Hold	200,000	–	–	﹤0.01%	891
2024 Q3	$2K	Hold	200,000	–	–	﹤0.01%	918
2024 Q2	$2.78K	Hold	200,000	–	–	﹤0.01%	923
2024 Q1	$2.08K	Hold	200,000	–	–	﹤0.01%	933
2023 Q4	$1.61K	Hold	200,000	–	–	﹤0.01%	906
2023 Q3	$10.5K	Hold	200,000	–	–	﹤0.01%	871
2023 Q2	$16.3K	Hold	200,000	–	–	﹤0.01%	886
2023 Q1	$17.4K	Hold	200,000	–	–	﹤0.01%	1019
2022 Q4	$32K	Hold	200,000	–	–	﹤0.01%	1007
2022 Q3	$82K	Hold	200,000	–	–	﹤0.01%	1080
2022 Q2	$59K	Buy	+200,000	New	+$74.5K	﹤0.01%	1138

Other funds holding PRENW

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Calamos Advisors's PRENW Position: Q2 2026 in Review

Calamos Advisors held its Prenetics Global Ltd Warrant (PRENW) position steady in Q2 2026 at 200,000 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

Calamos Advisors first reported a position in PRENW in Q2 2022 and has held it in 17 quarters since. The position peaked at $82K in Q3 2022. 2 funds tracked by Wall St. Rank hold PRENW as of Q2 2026.

Calamos Advisors held 200,000 shares of Prenetics Global Ltd Warrant worth $2.51K as of Q2 2026.
Calamos Advisors left its Prenetics Global Ltd Warrant share count unchanged in Q2 2026.
Prenetics Global Ltd Warrant made up ﹤0.01% of Calamos Advisors's portfolio in Q2 2026, its #973 holding.
Calamos Advisors first reported a position in Prenetics Global Ltd Warrant in Q2 2022 and has held it in 17 quarters since.
Calamos Advisors's Prenetics Global Ltd Warrant position peaked at $82K in Q3 2022.
2 funds tracked by Wall St. Rank held Prenetics Global Ltd Warrant as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.